Transporter Associated with antigen processing

Advances in Immunology

Volumn 65, Issue , 1997, Pages 47-109

  Elliott, Tim ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CELLULAR DISTRIBUTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GENE STRUCTURE; GENETIC REGULATION; GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; TARGET CELL; TRANSPORT KINETICS;

EID: 0030843345     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (215)

1. Zinkernagel, R. M., and Doherty, P. C. (1975). H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D. J. Exp. Med. 141, 1427-1436.
2. Doherty, P. C., and Zinkernagel, R. M. (1975). H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J. Exp. Med. 141, 502-507.
3. Doherty, P. C., and Zinkernagel, R. M. (1975). Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 256, 50-52.
4. Blanden, R. V., Doherty, P. C., Dunlop, M. B., Gardner, I. D., Zinkernagel, R. M., and David, C. S. (1975). Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex. Nature 254, 269-270.
5. Zweerink, H. J., Askonas, B. A., Millican, D., Courtneidge, S. A., and Skehel, J. J. (1977). Cytotoxic T cells to type A influenza virus; Viral hemaglutinin induces strain-A specificity while infected cells confer cross-reactive cytotoxicity. Eur. J. Immunol. 7, 630-635.
6. Zweerink, H. J., Courtneidge, S. A., Skehel J. J., Crumpton, M. J., and Askonas, B. A. (1977). Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature 267, 354-356.
7. Townsend, A. R., and Skehel, J. J. (1982). Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins. Nature 300, 655-657.
8. Effros, R. B., Doherty, P. C., Gerhard, W., and Bennink, J. (1977). Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J. Exp. Med. 145, 557-568.
9. Ada, G. L., and Yap, K. L. (1979). The measurement of haemagglutinin and matrix protein present on the surface of influenza virus infected P815 mastocytoma cells. J. Gen. Virol. 42, 541-553.
10. Biddison, W. E., Doherty, P. C, and Webster, R. G. (1977). Antibody to influenza vims matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses. J. Exp. Med. 146, 690-697.
11. Braciale, T. J. (1977). Immunologic recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells. J. Exp. Med. 146, 673-689.
12. Virelizier, J. L., Allison, A. C., Oxford, J. S., and Schild, G. C. (1977). Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells. Nature 266, 52-54.
13. Yewdell, J. W., Frank, E., and Gerhard, W. (1981). Expression of influenza A virus internal antigens on the surface of infected P815 cells. J. Immunol. 126, 1814-1819.
14. Townsend, A. R. M., McMichael, A. J., Carter, N. P., Huddleston, J. A., and Brownlee, G. G. (1984). Cytotoxic T cell recognition of the influenza nucleoprotein and haemag-glutinin expressed in transfected mouse L cells. Cell 39, 13-25.
15. Townsend, A. R., Gotch, F. M., and Davey, J. (1985). Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42, 457-467.
16. Townsend, A. R., Bastin, J., Gould, K., and Brownlee, G. G. (1986). Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence. Nature 324, 575-577.
17. Townsend, A. R., Rothbard, J., Gotch, F. M., Bahadur, G., Wraith, D., and McMichael, A. J. (1986). The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44, 959-968.
18. Heemels, M. T., and Ploegh, H. (1995). Generation, translocation and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64, 463-491.
19. Butcher, G. W., Corvalan, J. R., Licence, D. R., and Howard, J. C. (1982). Immune response genes controlling responsiveness to major transplantation antigens. Specific major histocompatibility complex-linked defect for antibody responses to class I alloan-tigens. J. Exp. Med. 155, 303-320.
20. Livingstone, A. M., Powis, S. J., Diamond, A. G., Butcher, G. W., and Howard, J. C. (1989). A trans-acting major histocompatibility complex-linked gene whose alleles determine gain and loss changes in the antigenic structure of a classical class I molecule. J. Exp. Med. 170, 777-795.
21. Powis, S. J., Howard, J. C., and Butcher, G. W. (1991). The major histocompatibility complex class II-linked cim locus controls the kinetics of intracellular transport of a classical class I molecule. J. Exp. Med. 173, 913-921.
22. Livingstone, A. M., Powis, S. J., Gunther, E., Cramer, D. V., Howard, J. C, and Butcher, G. W. (1991). Cim: An MHC class Il-linked allelism affecting the antigenicity of a classical class I molecule for T lymphocytes. Immunogenetics 34, 157-163.
23. Ljunggren, H. G., and Karre, K. (1985). Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162, 1745-1759.
24. Ljunggren, H. G., Paabo, S., Cochet, M., Kling, G., Kourilsky, P., and Karre, K. (1989). Molecular analysis of H-2-defitient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis. J. Immunol. 142, 2911-2917.
25. Townsend, A., Ohlen, C., Bastin, J., Ljunggren, H. G., Foster, L., and Karre, K. (1989). Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340, 443-448.
26. DeMars, R., Chang, C. C., Shaw, C., Reitnauer, P. J., and Sondel, P. M. (1984). Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B lymphoblastoid cells. Reduced proliferative responses of autologous and allogenic T cells to mutant cells that have decreased expression of class I antigens. Hum. Immunol. 11, 77-82.
27. Cerundolo, V., Alexander, J., Anderson, K., Lamb, C., Cresswell, P., McMichael, A., Gotch, F., and Townsend, A. (1990). Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 345, 449-452.
28. Ceman, S., Rudersdorf, R., Long, E. O., and DeMars, R. (1992). MHC class II deletion mutant expresses normal levels of transgene encoded class II molecules that have abnormal conformation and impaired antigen presentation ability. J. Immunol. 149, 754-761.
29. Deverson, E. V., Gow, I. R., Coadwell, W. J., Monaco, J. J., Butcher, G. W., and Howard, J. C. (1990). MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 348, 738-741.
30. Monaco, J. J., Cho, S., and Attaya, M. (1990). Transport protein genes in the murine MHC: Possible implications for antigen processing. Science 250, 1723-1726.
31. Brown, M. G., Driscoll, J., and Monaco, J. J. (1991). Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 353, 355-357.
32. Martinez, C. K., and Monaco, J. J. (1991). Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 353, 664-667.
33. Trowsdale, J., Hanson, I., Mockridge, I., Beck, S., Townsend, A., and Kelly, A. (1990). Sequences encoded in the class II region of the MHC related to the 'ABC superfamily of transporters. Nature 348, 741-744.
34. Powis, S. H., Mockridge, I., Kelly, A., Kerr, L. A., Glynne, R., Gileadi, U., Beck, S., and Trowsdale, J. (1992). Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. Proc. Natl. Acad. Sci. USA 89, 1463-1467.
35. Spies, T., Bresnahan, M., Bahram, S., Arnold, D., Blanck, G., Mellins, E., Pious, D., and DeMars, R. (1990). A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348, 744-747.
36. Bahram, S., Arnold, D., Bresnahan, M., Strominger, J. L., and Spies, T. (1991). Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc. Natl. Acad. Sci. USA 88, 10094-10098.
37. Hanson, I. M., and Trowsdale, J. (1991). Colinearity of novel genes in the class II regions of the MHC in mouse and human. Immunogenetics 34, 5-11.
38. Higgins, C. F. (1992). ABC transporters: From microorganisms to man. Annu. Rev. Cell. Biol. 8, 67-113.
39. The WHO Nomenclature Committee for factors of the HLA system (1991). Nomenclature factors of the HLA system, 1991. Immunogenetics 36, 135-148.
40. Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982). Distantly related sequences in the α- and b-subunits of ATP synthase, myosin kinases and other ATP requiring enzymes and a common nucleotide binding fold. EMBO J. 1, 945-951.
41. Higgins, C. F., Gallagher, M. P., Mimmack, M. L., and Pearce, S. R. (1988). A family of closely related ATP-binding subunits from prokaryotic and eukaryotic cells. Bioessays 8, 111-116.
42. Yang, Y., Fruh, K., Chambers, J., Waters, J. B., Wu, L., Spies, T., and Peterson, P. A. (1992). Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules. J. Biol. Chem. 267, 11669-11672.
43. Powis, S. J., Townsend, A. R., Deverson, E. V., Bastin, J., Butcher, G. W., and Howard, J. C. (1991). Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354, 528-531.
44. Attaya, M., Jameson, S., Martinez, C. K., Hermel, E., Aldrich, C., Forman, J., Lindahl, K. F., Bevan, M. J., and Monaco, J. J. (1992). Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355, 647-649.
45. Cerundolo, V., Kelly, A., Elliott, T., Trowsdale, J., and Townsend, A. (1995). Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immunol. 25(2), 554-562.
46. Loo, T., and Clarke, D., (1994). Reconstitution of drug-stimulated ATPase activity following co-expression of each half of human P-glycoprotein as separate polypeptides. J. Biol. Chem. 269(10), 7750-7755.
47. Hughes, A. L. (1994). Evolution of the ATP-binding-cassette transmembrane transporters of vertebrates. Mol. Biol. Evol. 11, 899-910.
48. Mccammon, M., Dowds, T. C., Orth, A. K., Moomaw, C., Slaughter, R. C., and Goodman, J. (1990). Sorting of peroxisomal membrane protein PMP47 from Candida boidinii into peroxisomal membranes of Saccharomyces cerevisiae. J. Biol. Chem. 265(33), 20098-20105.
49. Woese, C. (1991). The use of ribosomal RNA in reconstructing evolutionary relationships among bacteria. In Molecular Evolution (R. Selander, K. A. Clark, and T. Whittam, Eds.), pp. 1-24 Sinauer, Sunderland, MA.
50. Beck, S., Abdulla, S., Alderton, R., Glynne, P. R., Gut, I. I., Hosking, G. L., Jackson, K. A., Kelly, A., Newell, W., Sanseau, R. P., Radley, E., Thorpe, K., and Trowsdale, J. (1996). Evolutionary dynamics of non-coding sequences within the class II region of the human MHCJ. Mol. Biol. 255(1), 1-13.
51. Beck, S., Kelly, A., Radley, E., Khurshid, F., Alderton, R., and Trowsdale, J. (1992). DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing. J. Mol. Biol. 228(2), 433-441.
52. Wright, K. L., White, L. C., Kelly, A., Beck, S., Trowsdale, J., and Ting, P. (1995). J. Exp. Med. 181, 1459-1471.
53. Gaskins, H. R., Monaco, J. J., and Leiter, E. H. (1992). Expression of intra-MHC transporter (Ham) genes and class I antigens in diabetes-susceptible NOD mice [Letter; Comment J. Science 256, 1826-1821.
54. Spies, T., Cerundolo, V., Colonna, M., Cresswell, P., Townsend, A., and DeMars, R. (1992). Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355, 644-646.
55. Kelly, A., Powis, S. H., Kerr, L. A., Mockridge, I., Elliott, T., Bastin, J., Uchanska-Ziegler, B., Ziegler, A., Trowsdale, J., and Townsend, A. (1992). Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355, 641-644.
56. Spies, T., and DeMars, R. (1991). Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351, 323-324.
57. Neefjes, J. J., Momburg, F., and Hammerling, G. J. (1993). Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261, 769-771.
58. van Endert, P. M., Tampe, R., Meyer, T., Tisch, R., Bach, J., and McDevitt, H. O. (1994). A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1, 491-500.
59. Meyer, T., Van Endert, H. P., Uebel, M. S., Ehring, B., and Tampe, R. (1994). Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett. 351(3), 443-447.
60. Zhou, X., Glas, R., Momburg, F., Hammerling, G. J., Jondal, M., and Ljunggren, H. G. (1993). TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur. J. Immunol. 23, 1796-1801.
61. Esquivel, F., Yewdell, J., and Bennink, J. (1992). RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 175, 163-168.
62. Rotzschke, O., Falk, K., Faath, S., and Rammensee, H. (1991). On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174(5), 1059-1072.
63. Aosai, F., Ohlen, C., Ljunggren, H. G., Hoglund, P., Franksson, L., Ploegh, H., Townsend, A., Karre, K., and Stauss, H. J. (1991). Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur. J. Immunol. 21, 2767-2774.
64. Gabathuler, R., Reid, G., Kolaitis, G., Driscoll, J., and Jefferies, W. (1994). Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J. Exp. Med. 180(4), 1415-1425.
65. Koelling, R., and Hollenberg, C. P. (1994). The first hydrophobic segment of the ABC-transporter, Ste6, functions as a signal sequence. FEBS Lett. 351, 155-158.
66. Friedlander, M., and Blobel, G. (1985). Bovine opsin has more than one signal sequence. Nature 318, 338-343.
67. Russ, G., Esquivel, F., Yewdell, J., Cresswell, W. P., Spies, T., and Bennink, J. (1995). Assembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia viruses. J. Biol. Chem. 270(36), 21312-21318.
68. Loo, T. W., and Clarke, D. M. (1995). P-glycoprotein: Associations between domains and between domains and molecular chaperones. J. Biol. Chem. 270, 21839-21844.
69. Pind, S., Riordan, J. R., and Williams, D. B. (1994). Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269, 12784-12788.
70. Kleijmeer, M. J., Kelly, A., Geuze, H. J., Slot, J. W., Townsend, A., and Trowsdale, J. (1992). Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 357, 342-344.
71. Munro, S., and Pelham, H. R. B. (1987). A carboxyl-terminal signal prevents secretion of luminal ER proteins. Cell 48, 899-907.
72. Townley, F. M., and Pelham, H. R. B. (1994). The KKXX signal mediates retrieval of membrane proteins from the Golgi to the ER in yeast. Eur. J. Cell Biol. 64, 211-216.
73. Pelham, H. R. B., and Munro, S. (1993). Sorting of membrane proteins in the secretory pathway. Cell 75, 603-605.
74. Munro, S. (1995). An investigation of the role of transmembrane domains in Golgi protein retention. EMBO J. 14, 4695-4704.
75. Von Heijne, G. (1986). Net amino-terminal-carboxyl terminal charge imbalance may be important for signal sequence function in bacteria. J. Mol. Biol. 192, 287-290.
76. Hartmann, E., Rapaport, T. A., and Lodish, H. F. (1989). Predicting the orientation of eukaryotic membrane-spanning proteins. Proc. Natl. Acad. Sci. USA 86, 5786-5790.
77. Sipos, L., and Von Heijne, G. (1993). Predicting the topology of eukaryotic membrane proteins. Eur. J. Biochem. 213, 1333-1340.
78. Cartwright, C. P., and Tipper, D. J. (1991). In vivo topological analysis of Ste2, a yeast plasma membrane protein, by using beta-lactamase gene fusions. Mol. Cell. Biol. 11, 2620-2628.
79. Feldheim, D., Rothblatt, J., and Schekman, R. (1992). Topology and functional domains of Sec63p, an endoplasmic reticulum membrane protein required for secretory protein translocation. Mol. Cell. Biol. 12, 3288-3296.
80. Zhang, J. T., and Ling, V. (1991). Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation. J. Biol. Chem. 266, 18224-18232.
81. Reneke, J. E., Blumer, K. J., Courchesne, W. E., and Thorner, J. (1988). The carboxylterminal segment of the yeast alpha-factor receptor is a regulatory domain. Cell 55, 221-234.
82. Juranka, P., Zhang, F., Kulpa, J., Endicott, J., Blight, M., Holland, I. B., and Ling, V. (1992). Characterization of the hemolysin transporter, HlyB, using an epitope insertion. J. Biol. Chem. 267, 3764-3770.
83. Georges, E., Bradley G., Gariepy, J., and Ling, V. (1990). Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87, 152-156.
84. Yoshimura, A., Kuwazuru, Y., Sumizawa, T., Ichikawa, M., Ikeda, S. I., Uda, T., and Akiyama, S. I. (1989). Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. J. Biol. Chem. 264, 16282-16291.
85. Loo, T. W., and Clarke, D. M. (1995). Membrane topology of a cysteine-less mutant of human P-glycoprotein. J. Biol. Chem. 270, 843-848.
86. Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V., and Willing-ham, M. C. (1988). A retrovirus carrying an MDR1 complementary DNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA 85, 4486-4490.
87. Nijenhuis, M., Schmitt, S., Armandola, E. A., Obst, R., Brunner, J., and Haemmerling, G. J. (1996). Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing. J. Immunol. 156, 2186-2195.
88. Momburg, F., Armandola, E. A., Post, M., and Hammerling, G. J. (1996). Residues in TAP2 peptide transporters controlling substrate specificity. J. Immunol. 156, 1756-1763.
89. Kyte, J., and Doolittle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105-132.
90. Hofmann, K., and Stoffel, W. (1992). PROFILEGRAPH: An interactive graphical tool for protein sequence analysis. Comput. Appl. Biosci. 8, 331-337.
91. Hofmann, K. H., and Stoffel, W. S. (1993). TMbase: A database of membrane spanning protein segments. Biol. Chem. Hoppe-Seyler 347, 166-174.
92. Blake, C. (1983). Exons and the evolution of proteins. Trends Biochem. Sci., 11-13.
93. Allen, H., Fraser, J., Flyer, D., Calvin, S., and Flavell, R. (1986). Beta-2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2D-b or of a truncated H-2D-b. Proc. Natl. Acad. Sci. USA 83, 7447-7451.
94. Elliott, T., Elvin, J., Cerundolo, V., Allen, H., and Townsend, A. (1992). Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains. Eur. J. Immunol. 22, 2085-2091.
95. Elliott, T., Elvin, J., Cerundolo, V., Allen, H., and Townsend, A. (1992). Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains. Eur. J. Immunol. 22, 2085-2091.
96. Go, M. (1983). Modular structural units, exons, and function in chicken lysozyme. Proc. Natl. Acad. Sci. USA 80, 1964-1968.
97. Gileadi, U., and Higgins, C. F. (1996). Membrane topology of the ABC transporters associated with peptide antigen presentation (TAP1). Submitted for publication.
98. Gafvelin, G., and Von Heijne, G. (1994). Topological "frustration" in multispanning E. coli inner membrane proteins. Cell 77, 401-412.
99. Colonna, M., Bresnahan, M., Bahram, S., Strominger, J. L., and Spies, T. (1992). Allelic variants of the human putative peptide transporter involved in antigen processing. Proc. Natl. Acad. Sci. USA 89, 3932-3936.
100. Szafer, F., Oksenberg, J. R., and Steinman, L. (1994). New allelic polymorphism in TAP genes. Immunogenetics 39, 374.
101. Powis, S., Tonks, H. S., Mockridge, I., Kelly, A., Bodmer, P. J., and Trowsdale, J. (1993). Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 37(5), 373-380.
102. Joly, E., Deverson, E. V., Coadwell, J. W., Guenther, E., Howard, J. C, and Butcher, G. W. (1994). The distribution of Tap2 alleles among laboratory rat TR1 haplotypes. Immunogenetics 40, 45-53.
103. Chen, H. L., Gabrilovich, D., Tampe, R., Girgis, K. R., Nadaf, S., and Carbone, D. P. (1996). A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer. Nature Genet. 13, 210-213.
104. De La Salle, H., Hanau, D., Flicker, D., Urlacher, A., Kelly, A., Salamero, J., Powis, S., Donato, H. L., Bausinger, H., Bausinger, H., Laforet, M., Jeras, M., Spehner, D., Bieber, T., Falkenrodt, A., Cazenave, J.-P., Trowsdale, J., and Tonigo, M.-M. (1994). Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265, 237-241.
105. Van Kaer, L., Ashton-Rickardt, P., Ploegh, H., and Tonegawa, S. (1992). TAP1 mutant mice are deficient in antigen presentation, surface class I molecules and CD4-8+ T cells. Cell 71, 1205-1214.
106. Levy, F., Gabathuler, R., Larsson, R., and Kvist, S. (1991). ATP is required for in vitro assembly of MHC class I antigens but not for transfer of peptides across the ER membrane. Cell 67, 265-274.
107. Koppelman, B., Zimmerman, D. L., Walter, P., and Brodsky, F. M. (1992). Evidence for peptide transport across microsomal membranes. Proc. Natl. Acad. Sci. USA 89, 3908-3912.
108. Hart, G. W., Brew, K., Grant, G. A., Bradshaw, R. A., and Lennarz, W. J. (1979). Primary structural requirements for enzymatic formation of the N-glycosidic bond in glycoproteins. J. Biol. Chem. 254, 9747-9753.
109. Lau, J. T. Y., Welpy, J. K., Shenbagamurthi, P., Naider, F., and Lennarz, W. J. (1983). Substrate recognition by oligosaccharyl transferase. J. Biol. Chem. 258, 15255-15260.
110. Anderson, K., Cresswell, P., Gammon, M., Hermes, J., Williamson, A., and Zweerink, H. (1991). Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174, 489-492.
111. Elliott, T., Willis, A., Cerundolo, V., and Townsend, A. (1995). Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181, 1481-1491.
112. Shepherd, J. C., Schumacher, T. N., Ashton Rickardt, P. G., Imaeda, S., Ploegh, H. L., Janeway, C. A. J., and Tonegawa, S. (1993). TAPl-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74, 577-584.
113. Androlewicz, M. J., Anderson, K. S., and Cresswell, P. (1993). Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl. Acad. Sci. USA 90, 9130-9134.
114. Yang, B., and Braciale, T. (1995). Characteristics of ATP-dependent peptide transport in isolated microsomes. J. Immunol. 155(8), 3889-3896.
115. Schumacher, T., Kantesaria, M. D., Heemels, V. M., Ashton Rickardt, T. P., Shepherd, G. J., Fruh, C. K., Yang, Y., Peterson, P., Tonegawa, A. S., and Ploegh, H. (1994). Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J. Exp. Med. 179(2), 533-540.
116. Momburg, F., Roelse, J., Hammerling, G. J., and Neefjes, J. J. (1994). Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med. 179, 1613-1623.
117. Gromme, M., van der Valk, R., Sliedregt, K., Liskamp, R., Hammerling, G., Koopmann, J., Momburg, F., and Neefjes, J. (1997). The rational design of inhibitors for the transporter associated with antigen processing using peptide substrate modifications and peptidomimetics.. Submitted for publication.
118. Heemels, M., Schumacher, T. T., Wonigeit, M. K., and Ploegh, H. (1993). Peptide translocation by variants of the transporter associated with antigen processing. Science 262(5142), 2059-2063.
119. Heemels, M. T., and Ploegh, H. L. (1994). Substrate specificity of allelic variants of the TAP peptide transporter. Immunity 1, 775-784.
120. Koopmann, J., Post, M., Neefjes, J., Hammerling, G. J., and Momburg, F. (1996). Translocation of long peptides by transporters associated with antigen processing (TAP). Eur. J. Immunol. 26, 1720-1728.
121. Momburg, F., Roelse, J., Howard, J., Rutcher, C. G., Hammerling, W. G., and Neefjes, J. (1994). Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367, 648-651.
122. Neefjes, J., Gottfried, E., Roelse, J., Gromme, M., Obst, R., Haemmerling, G., and Momburg, F. (1995). Analysis of the fine specificity of rat, mouse and human TAP peptide transporters. Eur. J. Immunol. 25(4), 1133-1136.
123. Snyder, H. L., Yewdell, J. W., and Rennink, J. (1994). Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180, 2389-2394.
124. Obst, R., Armandola, E., Nijenhuis, A. M., Momburg, F., and Haemmerling, G. (1995). TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur. J. Immunol. 25(8), 2170-2176.
125. Armandola, E. A., Momburg, F., Nijenhuis, M., Hulbuc, N., Fruh, K., and Hammerling, G. J. (1996). A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity. Eur. J. Immunol. 26, 1748-1755.
126. Momburg, F., Armandola, E. A., Post, M., and Hammerling, G. J. (1996). Residues in TAP2 peptide transporters controlling substrate specificity. J. Immunol. 156, 1756-1763.
127. Elliott, T., Smith, M., Driscoll, P., and McMichael, A. (1994). Peptide selection by class I molecules of the major histocompatibility complex. Curr. Biol. 3, 854-866.
128. Powis, S. J., Young, L. L., Joly, E., Barker, P. J., Richardson, L., Brandt, R. P., Melief, C. J., Howard, J. C., and Butcher, G. W. (1996). The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. Immunity 4, 159-165.
129. Uebel, S., Meyer, T., Kraas, H. W., Kienle, S., Jung, G., Wiesmueller, K., and Tampe, R. (1995). Requirements for peptide binding to the human transporter associated with antigen processing revealed by peptide scans and complex peptide libraries. J. Biol. Chem. 270(31), 18512-18516.
130. Androlewicz, M. J., and Cresswell, P. (1994). Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1, 7-14.
131. Zhang, X., Collins, K. I., and Greenberger, L. M. (1995). Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1. J. Biol. Chem. 270, 5441-5448.
132. Greenberger, L. M. (1993). Major photoaffinity drug labeling sites for iodoaryl azidopra-zosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12. J. Biol. Chem. 268, 11417-11425.
133. Mueller, K., Ebensperger, M. C., and Tampe, R. (1994). Nucleotide binding to the hydrophilic C-terminal domain of the transporter associated with antigen processing (TAP). J. Biol. Chem. 269(19), 14032-14037.
134. Valverde, M., Diaz, A. M., Sepulveda, F., Gill, V. D., Hyde, R. S., and Higgins, C. (1992). Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 355, 830-833.
135. Gill, D., Hyde, R. S., Higgins, C. C., Valverde, F. M., Mintenig, A. G., and Sepulveda, F. (1992). Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71(1), 23-32.
136. Higgins, C. F. (1995). P-glycoprotein and cell volume-activated chloride channels. J. Bioener. Biomembr. 27(1), 63-70.
137. Covitz, K., Panagioridis, Y. C., Hor, H. L., Reyes, I. M., Treptow, N., and Shuman, A. (1994). Mutations that alter the transmembrane signalling pathway in an ATP binding cassette (ABC) transporter. EMBO J. 13(7), 1752-1759.
138. Suh, W., Cohen Doyle, K. M., Fruh, F. K., Wang, K., Peterson, P., and Williams, D. (1994). Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264, 1322-1326.
139. Ortmann, B., Androlewicz, M. J., and Cresswell, P. (1994). MHC class I/beta-2 microglobulin complexes associate with TAP transporters before peptide binding. Nature 368, 864-867.
140. Androlewicz, M. J., Ortmann, B., van Endert, P. M., Spies, T., and Cresswell, P. (1994). Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc. Natl. Acad. Sci. USA 91, 12716-12720.
141. Suh, W., Mitchell, E. K., Yang, Y., Peterson, P., Waneck, G. L., and Williams, D. B. (1996). MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J. Exp. Med. 184, 337-348.
142. Neefjes, J. J., Hammerling, G. J., and Momburg, F. (1993). Folding and assembly of major histocompatibility complex class I heterodimers in the endoplasmic reticulum of intact cells precedes the binding of peptide. J. Exp. Med. 178, 71-80.
143. Bergeron, J. J. M., Brenner, M. B., Thomas, D. Y., and Williams, D. B. (1994). Calnexin: A membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 19, 124-128.
144. Degen, E., and Williams, D. B. (1991). Participation of a novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules. J. Cell. Biol. 112, 1099-1115.
145. Degen, E., Cohen Doyle, M. F., and Williams, D. B. (1992). Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide. J. Exp. Med. 175, 1653-1661.
146. Rajagopalan, S., Xu, Y., and Brenner, M. B. (1994). Retention of unassembled components of integral membrane proteins by calnexin. Science 263, 387-390.
147. Nossner, E., and Parham, P. (1995). Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J. Exp. Med. 181, 327-337.
148. Sadasivan, B., Lehner, P. J., Ortmann, B., Spies, T., and Cresswell, P. (1996). Roles for calreticulin and a novel glycoprotein, tapaisin, in the interaction of MHC class I molecules with the transporters associated with antigen processing (TAP). Immunity 5, 103-114.
149. Ortmann, B., Androlewicz, M., and Cresswell, P. (1994). MHC class I/beta-2-micro-globulin complexes associate with TAP transporters before peptide binding. Nature 368, 864-867.
150. Greenwood, R., Shimizu, Y., Sekhon, G. S., and DeMars, R. (1994). Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J. Immunol. 153, 5525-5536.
151. Grandea, A. G., Androlewicz, M. J., Athwal, R. S., Geraghty, D. E., and Spies, T. (1995). Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270, 105-108.
152. Tame, J. R. H., Murshudov, G. N., Dodson, E. J., Neil, T. K., Dodson, G. G., Higgins, C. F., and Wilkinson, A. J. (1994). Structural basis of sequence-independent peptide binding by OppA protein. Science 264, 1578-1581.
153. Carreno, B. M., Solheim, J. C., Harris, M., Stroynowski, I., Connolly, J. M., and Hansen, T. H. (1995). TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man. J. Immunol. 155, 4726-4733.
154. Neisig, A., Wubbolts, R., Zang, X., Melief, C, and Neefjes, J. (1996). Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156, 196-206.
155. Lewis, J. W., Neisig, A., Neefjes, J., and Elliott, T. (1996). Point mutations in the alpha-2 domain of HLA-A2.1 define a functionally relevant interaction with TAP. Curr. Biol. 6, 873-883.
156. Peace-Brewer, A. L., Tussey, L., Matsui, M., Li, G., Quinn, D. G., and Freligger, J. A. (1996). A point mutation in HLA-A°0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity 4, 505-514.
157. Van Endert, P., Liblau, M. R., Patel, S. S., Fugger, D. L., Lopez, T., Pociot, F., Nerup, J., and McDevitt, H. (1994). Major histocompatibility: Complex-encoded antigen processing gene polymorphism in IDDM. Diabetes 43(1), 110-117.
158. Caillat-Zucmann, S., Bertin, E., Timsit, J., Boitard, C., Assan, R., and Bach, J. F. (1993). Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur. J. Immunol. 23, 1784-1788.
159. Bendelak, A., Carnaud, C., Boitard, C, and Bach, J. F. (1987). Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates: Requirement for both L3T4+ and Lyt2+ T cells. J. Exp. Med. 166, 823-832.
160. Gaskins, H. R., Monaco, J. J., and Leiter, E. H. (1992). Expression of intra-MHC transporter (Ham) genes and class I antigens in diabetes-susceptible NOD mice. Science 256, 1826-1828.
161. Li, F., Guo, J., Fu, Y., Yan, G., and Faustman, D. (1994). Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse. Proc. Natl. Acad. Sci. USA 91, 11128-11132.
162. Faustman, D., Li, X. P., Lin, H. Y., Fu, Y. E., Eisenbarth, G., Avruch, J., and Guo, J. (1991). Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science 254, 1756-1761.
163. Pearce, R., Trigler, B. L., Svaasand, E., Chen, K. H., and Peterson, C. (1995). Levels of Tap-1 and Tap-2 mRNA and expression of K-d and D-b on splenic lymphocytes are normal in NOD mice. Diabetes 44(5), 572-579.
164. Wicker, L. S., Podolin, P. L., Fischer, P., Sirotina, A., Boltz, R. C. J., and Peterson, L. B. (1992). Expression of intra-MHC transporter (Ham) genes and class I antigens in diabetes-susceptible NOD mice. Science 256, 1828-1830.
165. Benjamin, R., and Parham, P. (1990). Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11, 137-142.
166. Barron, K., Reveille, S. J., Carrington, D. M., Mann, D., and Robinson, M. (1995). Susceptibility to Reiter's syndrome is associated with alleles of tap genes. Arthritis Rheum. 38(5), 684-689.
167. Burney, R., Pile, O. K., Gibson, D. K., Calin, A., Kennedy, L., Sinnott, G. P., Powis, J. S., and Wordsworth, B. (1994). Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann. Rheum. Dis. 53(1), 58-60.
168. Elliott, T. (1996). Tapping into tumours. Nature Genet. 13, 139-140.
169. Browning, M. J., and Bodmer, W. F. (1996). MHC antigens and cancer: Implications for T-cell surveillance. Curr. Opin. Immunol. 4, 613-618.
170. Salcedo, M., Momburg, F., Hammerling, G. J., and Ljunggren, H. G. (1994). Resistance to natural killer cell lysis conferred by TAP 1/2 genes in human antigen-processing mutant cells. J. Immunol. 152, 1702-1708.
171. Fruh, K., Ahn, K., Djaballah, H., Sempe, P., Van Endert, P., Tampe, R., Peterson, P., and Yang, Y. (1995). A viral inhibitor of peptide transporters for antigen presentation. Nature 375(6530), 415-418.
172. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., and Johnson, D. (1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature 375(6530), 411-415.
173. Tomazin, R., Hill, A. B., Jugovic, P., York, I., van Endert, P., Ploegh, H., Andrews, D. W., and Johnson, D. C. (1996). Stable binding of the herpes simplx virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15, 3256-3266.
174. Ahn, K., Meyer, T. H., Uebel, S., Sempe, P., Djaballah, H., Yang, Y., Peterson, P. A., Fruh, K., and Tampe, R. (1996). Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47. EMBO J. 15, 3247-3255.
175. York, I., Roop, C., Andrews, D. W., Riddel, S. R., Graham, F. L., and Johnson, D. C. (1994). A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 11, 525-535.
176. Salter, R., and Cresswell, P. (1986). Impaired assembly and transport of HLA-A and -B antigens in a mutant T X B cell hybrid. EMBO J. 5, 943-949.
177. Klar, D., and Hammerling, G. (1989). Induction of assembly of MHC class I heavy chains with β2-m by interferon-gamma. EMBO J. 8, 475-481.
178. Sibille, C., Gould, K., Hammerling, G., and Townsend, A. (1992). A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly. Eur. J. Immunol. 22, 433-440.
179. Lobigs, M., and Mullbacher, A. (1995). Recombinant expression of vaccinia virus-encoded TAP1 and TAP2 promotes MHC class I-restricted antigen presentation in a Syrian hamster cell line. Immunol. Cell Biol. 73(2), 181-184.
180. Kuroda, K., Yamashina, K., Kitatani, N., Kagishima, A., Hamaoka, T., and Hosaka, Y. (1995). Characterization of defectiveness in endogenous antigen presentation of novel murine cells established from methylcholanthrene-induced fibrosarcomas. Immunology 84(1), 153-158.
181. Bikoff, E. K., Jaffe, L., Ribaudo, R. K., Otten, G. R., Germain, R. N., and Robertson, E. J. (1991). MHC class I surface expression in embryo-derived cell lines inducible with peptide or interferon. Nature 354, 235-238.
182. Jackson, D., and Capra, J. (1993). TAP1 alleles in insulin-dependent diabetes mellitus: A newly defined centromeric boundary of disease susceptibility. Proc. Natl. Acad. Sci. USA 90(23), 11079-11083.
183. Jackson, D., and Capra, J. (1995). TAP2 association with insulin-dependent diabetes mellitus is secondary to HLA-DQB1. Hum. Immunol. 43(1), 57-65.
184. Cucca, F., Congia, M., Trowsdale, J., and Powis, S. (1994). Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: No association in a population with a high disease incidence. Tissue Antigens 44(4), 234-240.
185. Nakanishi, K., Kobayashi, T., Murase, T., and Kosaka, K. (1994). Lack of association of the transporter associated with antigen processing with Japanese insulin-dependent diabetes mellitus. Metab. Clin. Exp. 43(8), 1013-1017.
186. Kawaguchi, Y., Ikegami, H., Fukuda, M., Takekawa, K., Fujioka, Y., Fujisawa, T., Ueda, H., and Ogihara, T. (1994). Absence of association of TAP and LMP genes with type 1 (insulin-dependent) diabetes mellitus. Life Sci. 54(26), 2049-2053.
187. Yamazaki, Y., Miyokawa, N., and Katagiri, M. (1994). Polymorphism of the TAP genes Japanese healthy control and type I diabetes mellitus. Hokkaido J. Med. Sci. 69(2), 337-346.
188. Esposito, L., Lampasona, V., Bosi, E., Poli, F., Ferrari, M., and Bonifacio, E. (1995). HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: No evidence for an additional contribution to disease risk by the TAP2 locus. Diabetologia 38(8), 968-974.
189. Gonzalez, E. M. F., Morales, J., Garcia, L. J. R., Castillo, M. J., Sanchez, R. J., Nunez, R. A., and Sanchez, B. (1995). TAP polymorphism in patients with Behcet's disease. Ann. Rheum. Dis. 54, 386-388.
190. Vandevyver, C., Geusens, P., Cassiman, J. J., and Raus, J. (1995). Peptide transporter genes (TAP) polymorphisms and genetic susceptibility to rheumatoid arthritis. Br. J. Rheumatol. 34, 207-214.
191. Kuwata, S., Yanagisawa, M., Saeki, H., Nakagawa, H., Etoh, T., Tokunaga, K., Juji, T., and Shibata, Y. (1995). Lack of primary association between transporter associated with antigen processing genes and atopic dermatitis. J. Allergy Clin. Immunol. 9, 1051-1060.
192. Kuwata, S., Yanagisawa, M., Saeki, H., Nakagawa, H., Etoh, T., Tokunaga, K., Juji, T., and Shibata, Y. (1994). Polymorphisms of transporter associated with antigen processing genes in atopic dermatitis. J. Allergy Clin. Immunol. 94, 565-574.
193. Liblau, R., van Endert, P., Wollheim, M., Sandberg, M. S., Patel, D. M., Lopez, T. S., Land, L., Fugger, H., and Mcdevitt, O. (1993). Antigen processing gene polymorphisms in HLA-DR2 multiple sclerosis. Neurology 43(6), 1192-1197.
194. Bell, R., and Ramachandran, S. (1995). The relationship of TAP1 and TAP2 dimorphisms to multiple sclerosis susceptibility. J. Neuroimmunol. 59, 201-204.
195. Djilali Saiah, I., Caillat Zucman, S., Schmitz, J., Chaves Vieira, M., and Bach, J. (1994). Polymorphism of antigen processing (TAP, LMP) and HLA class II genes in celiac disease. Hum. Immunol. 40(1), 8-16.
196. Ploski, R., Undlien, D., Vinje, E. O., Forre, O., Thorsby, E., and Ronningen, K. (1994). Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) genes and susceptibility to juvenile rheumatoid arthritis. Hum. Immunol. 39(1), 54-60.
197. Gregory, W., Daly, L. A., Dunn, K. A., Cavanagh, N. G., Idle, J., James, R. O., and Bassendine, M. (1994). Analysis of HLA-class-II-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis. Quart. J. Med. 87(4), 237-244.
198. Savage, D., Ng, A. S., Howe, C. H., Ngai, S. J., Darke, F. C, and Hui, K. (1995). HLA and TAP associations in Chinese systemic lupus erythematosus patients. Tissue Antigens 46, 213-216.
199. Chewier, D., Giral, M., Braud, V., Bourbigot, B., Muller, J., Bignon, Y. J., and Soulillou, J. (1995). Effects of MHC-encoded TAPl and TAP2 gene polymorphism and matching on kidney graft rejection. Transplantation 60, 292-296.
200. Fakler, J. W., Schmitt, E. M., Vejbaesya, S., Boehncke, W. H., Sterry, W., and Eier-mann, T. H. (1994). Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis. Hum. Immunol. 40, 299-302.
201. Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mule, J. J., Rosenberg, S. A., and Bennink, J. R. (1993). Identification of human cancers deficient in antigen processing. J. Exp. Med. 177, 265-272.
202. Korkolopoulou, P., Kaklamanis, L., Pezzella, F., Harris, A., and Gatter, K. (1996). Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br. J. Cancer 73(2), 148-153.
203. Fisk, B., Ioannides, C., Aggarwal, G. S., Wharton, J., O'Brian, T. C., Restifo, A. N., and Clisson, B. (1994). Enhanced expression of HLA-A, B, C and inducibility of TAP-1, TAP-2, and HLA-A, B, C by interferon-gamma in a multidrug-resistant small cell lung cancer line. Lymphokine Cytokine Res. 13(2), 125-131.
204. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K., and Harris, A. (1995). Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res. 55(22), 5191-5194.
205. Cromme, F., Airey, V. J., Heemels, M., Ploegh, T. H., Keating, L. P., Stern, J. P., Meijer, L. C, and Walboomers, J. (1994). Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med. 179(1), 335-340.
206. Cromme, F., Van Bommel, V. P., Walboomers, J. J., Gallee, M., Stern, W. P., Kenemans, L. P., Helmerhorst, T., Stukart, M. M., and Meijer, C. (1994). Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br. J. Cancer 69(6), 1176-1181.
207. Kalamanis, L., Townsend, A., Doussis Anagnostopoulou, I., Mortensen, A. N., Harris, A., and Gatter, K. (1994). Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am. J. Pathol. 145(3), 505-509.
208. Keating, P., Cromme, J. F., Duggan Keen, V. M., Snijders, P., Walboomers, F. J., Hunter, M. R., Dyer, D. P., and Stern, P. (1995). Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br. J. Cancer 72(2), 405-411.
209. Sanda, M., Restifo, G. N., Walsh, P. J., Kawakami, C. Y., Nelson, W., Pardoll, G. D., and Simons, J. (1995). Molecular characterization of defective antigen processing in human prostate cancer. J. Natl. Cancer Inst. 87(4), 280-285.
210. Roby, K. F., Fei, K., Yang, Y., and Hunt, J. (1994). Expression of HLA class II-associated peptide transporter and proteasome genes in human placentas and trophoblast cell lines. Immunology 83(3), 444-448.
211. Epperson, D. E., Arnold, D., Spies, T., Cresswell, P., Pober, J., and Johnson, D. R. (1992). Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in epithelial cells. J. Immunol. 149, 3297-3301.
212. Roby, K. F., Gershon, D., and Hunt, J. S. (1996). Expression of the transporter for antigen processing-1 (Tap-1) gene in subpopulations of human trophoblast cells. Placenta 17, 27-32.
213. Clover, L. M., Sargent, I. L., Townsend, A., Tampe, R., and Redman, C. W. G. (1995). Expression of TAP1 by human trophoblast. Eur. J. Immunol. 25, 543-548.
214. Franksson, L., George, E., Powis, S., Butcher, G., Howard, J., and Karre, K. (1993). Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene. J. Exp. Med. 177(1), 201-205.
215. Salcedo, M., Momburg, F., Haemmerling, G., and Ljunggren, H. (1994). Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells. J. Immunol. 152(4), 1702-1708.